loadpatents
name:-0.020488023757935
name:-0.019870042800903
name:-0.0005490779876709
Lin; Ko-Chung Patent Filings

Lin; Ko-Chung

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lin; Ko-Chung.The latest application filed is for "method of using pegylated interferon-alpha".

Company Profile
0.29.21
  • Lin; Ko-Chung - Lexington MA
  • Lin; Ko-Chung - St. Louis MO
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method Of Using Pegylated Interferon-alpha
App 20220152156 - Lin; Ko-Chung ;   et al.
2022-05-19
Dosage Regimen For Pegylated Interferon
App 20170326206 - Klade; Christoph ;   et al.
2017-11-16
Synthesis of 5-deoxy-5'-fluorocytidine compounds
Grant 8,975,393 - Lin , et al. March 10, 2
2015-03-10
Therapeutic use of interferon-polymer conjugates
Grant 8,617,532 - Lin , et al. December 31, 2
2013-12-31
Novel Synthesis Of 5-deoxy-5'-fluorocytidine Compounds
App 20130184451 - Lin; Ko-Chung ;   et al.
2013-07-18
Protein-polymer conjugates
Grant 8,273,343 - Lin September 25, 2
2012-09-25
Protein-polymer conjugates
Grant 8,143,214 - Lin March 27, 2
2012-03-27
Theapeutic Use Of Protein-polymer Conjugates
App 20110262380 - Lin; Ko-Chung ;   et al.
2011-10-27
Peptide-polymer Conjugates
App 20110098451 - Lin; Ko-Chung
2011-04-28
Peptide-polymer Conjugates
App 20100029907 - Lin; Ko-Chung
2010-02-04
Adenosine receptor antagonists and methods of making and using the same
Grant 7,579,354 - Kiesman , et al. August 25, 2
2009-08-25
Protein-polymer Conjugates
App 20090053177 - Lin; Ko-Chung
2009-02-26
Stereoselective synthesis of .beta.-nucleosides
Grant 7,485,716 - Lin , et al. February 3, 2
2009-02-03
Retroviral protease inhibitors
App 20080103311 - Tally; John J. ;   et al.
2008-05-01
Retroviral protease inhibitors
Grant 7,312,333 - Talley , et al. December 25, 2
2007-12-25
Stereoselective synthesis of beta-nucleosides
App 20070042987 - Lin; Ko-Chung ;   et al.
2007-02-22
Stereoselective synthesis of beta-nucleosides
App 20070015914 - Lin; Ko-Chung ;   et al.
2007-01-18
Adenosine receptor antagonists and methods of making and using the same
App 20070015732 - Kiesman; William F. ;   et al.
2007-01-18
Adenosine receptor antagonists and methods of making and using the same
App 20060252730 - Kiesman; William F. ;   et al.
2006-11-09
Cell adhesion inhibitors
App 20060166866 - Adams; Steven P. ;   et al.
2006-07-27
Retroviral protease inhibitors
App 20060166895 - Talley; John J. ;   et al.
2006-07-27
Retroviral protease inhibitors
Grant 7,026,485 - Talley , et al. April 11, 2
2006-04-11
A1 adenosine receptro antagonists
Grant 7,022,686 - Lin , et al. April 4, 2
2006-04-04
Cell adhesion inhibitors
Grant 7,001,921 - Adams , et al. February 21, 2
2006-02-21
Cell adhesion inhibitors
Grant 6,875,743 - Lin , et al. April 5, 2
2005-04-05
Retroviral protease inhibitors
App 20050004230 - Talley, John J. ;   et al.
2005-01-06
Retroviral protease inhibitors
Grant 6,762,187 - Talley , et al. July 13, 2
2004-07-13
Adenosine receptor antagonists and methods of making and using the same
App 20040067966 - Kiesman, William F. ;   et al.
2004-04-08
A1 adenosine receptro antagonists
App 20030220358 - Lin, Ko-Chung ;   et al.
2003-11-27
Adenosine receptor antagonists and methods of making and using the same
Grant 6,649,600 - Kiesman , et al. November 18, 2
2003-11-18
Retroviral protease inhibitors
App 20030195227 - Talley, John J. ;   et al.
2003-10-16
Cell adhesion inhibitors
Grant 6,630,512 - Adams , et al. October 7, 2
2003-10-07
Cell adhesion inhibitors
Grant 6,624,152 - Adams , et al. September 23, 2
2003-09-23
A1 adenosine receptor antagonists
Grant 6,605,601 - Lin , et al. August 12, 2
2003-08-12
Cell adhesion inhibitors
Grant 6,596,687 - Lin , et al. July 22, 2
2003-07-22
Cell adhesion inhibitors
App 20030083267 - Adams, Steven P. ;   et al.
2003-05-01
Cell adhesion inhibitors
App 20030018016 - Adams, Steven P. ;   et al.
2003-01-23
Retroviral protease inhibitors
Grant 6,506,759 - Talley , et al. January 14, 2
2003-01-14
A1 adenosine receptor antagonists
App 20020111333 - Lin, Ko-Chung ;   et al.
2002-08-15
Retroviral protease inhibitors
Grant 6,180,646 - Talley , et al. January 30, 2
2001-01-30
Retroviral protease inhibitors
Grant 5,948,790 - Talley , et al. September 7, 1
1999-09-07
Retroviral protease inhibitors
Grant 5,756,534 - Talley , et al. May 26, 1
1998-05-26
Retroviral protease inhibitors
Grant 5,703,076 - Talley , et al. December 30, 1
1997-12-30
Retroviral protease inhibitors
Grant 5,648,364 - Talley , et al. July 15, 1
1997-07-15
Retroviral protease inhibitors
Grant 5,643,924 - Talley , et al. July 1, 1
1997-07-01
Retroviral protease inhibitors
Grant 5,620,977 - Talley , et al. April 15, 1
1997-04-15
Retroviral protease inhibitors
Grant 5,482,947 - Talley , et al. January 9, 1
1996-01-09
Retroviral protease inhibitors
Grant 5,475,013 - Talley , et al. December 12, 1
1995-12-12
Retroviral protease inhibitors
Grant 5,475,027 - Talley , et al. December 12, 1
1995-12-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed